Optimal dosage and differences in therapeutic efficacy of IGIV in Kawasaki disease-Reference-Cited by-同舟云学术

Optimal dosage and differences in therapeutic efficacy of IGIV in Kawasaki disease

Published:1995-02 Issue:1 Volume:37 Page:40-46
ISSN:1328-8067
Container-title:Pediatrics International
language:en
Short-container-title:

Author:

ONOUCHI ZENSHIRO,YANAGISAWA MASAYOSHI,HIRAYAMA TSUNEO,KIYOSAWA NOBUYUKI,MATSUDA HIROSHI,NAKASHIMA MITSUYOSHI

Publisher

Wiley

Subject

Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-200X.1995.tb03683.x/fullpdf

Reference20 articles.

1. High-dose intravenous gammaglobulin for Kawasaki disease;Furusho;Lancet,1984

2. Research Committee on Kawasaki Disease by Ministry of Health and Welfare (Japan) Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease 1984

3. Diagnosis and therapy of Kawasaki disease in children;Dajani;Circulation,1993

4. Intravenous gamma globulin treatment in Kawasaki disease - comparison between high dose and low dose Kawasaki Disease Research Group, Supported by Ministry of Health and Welfare;Harada;Prog. Med.,1989

5. Clinical evaluation of gamma globulin preparation for the treatment of Kawasaki disease - Trial of 400 mg/ kg/day for 3 days;Ogawa;J. Jap. Pediatr. Soc.,1987

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous immunoglobulin for the treatment of Kawasaki disease;Cochrane Database of Systematic Reviews;2023-01-25

2. Intravenous Immunoglobulin in Lupus Panniculitis;Clinical Reviews in Allergy & Immunology;2009-06-27

3. Intravenous immunoglobulin for the treatment of Kawasaki disease in children;Cochrane Database of Systematic Reviews;2003-10-20

4. A study of 20 SLE patients with intravenous immunoglobulin clinical and serologic response;Lupus;1999-11